Table of Contents
ISRN Pharmacology
Volume 2013 (2013), Article ID 303717, 8 pages
http://dx.doi.org/10.1155/2013/303717
Research Article

Effects of Thyroid Hormone Analogue and a Leukotrienes Pathway-Blocker on Reperfusion Injury Attenuation after Heart Transplantation

Surgical Department, Medical College, Kufa University, Kufa Street, Najaf, Iraq

Received 10 July 2013; Accepted 14 August 2013

Academic Editors: A. Fernandez-Guasti and D. K. Miller

Copyright © 2013 Fadhil G. Al-Amran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Land and K. Messmer, “The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation,” Transplantation Reviews, vol. 10, no. 2, pp. 108–127, 1996. View at Google Scholar · View at Scopus
  2. W. Land, H. Schneeberger, S. Schleibner et al., “The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants,” Transplantation, vol. 57, no. 2, pp. 211–217, 1994. View at Google Scholar · View at Scopus
  3. H. S. Sharma and D. K. Das, “Role of cytokines in myocardial ischemia and reperfusion,” Mediators of Inflammation, vol. 6, no. 3, pp. 175–183, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Gillard, A. W. Ford-Hutchinson, C. Chan et al., “L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor,” Canadian Journal of Physiology and Pharmacology, vol. 67, no. 5, pp. 456–464, 1989. View at Google Scholar · View at Scopus
  5. P. J. Vickers, “5-Lipoxygenase-activating protein (FLAP),” Journal of Lipid Mediators and Cell Signalling, vol. 12, no. 2-3, pp. 185–194, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Rouzer, A. W. Ford-Hutchinson, H. E. Morton, and J. W. Gillard, “MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes,” The Journal of Biological Chemistry, vol. 265, no. 3, pp. 1436–1442, 1990. View at Google Scholar · View at Scopus
  7. H. A. Lehr, A. Guhlmann, D. Nolte, D. Keppler, and K. Messmer, “Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster,” Journal of Clinical Investigation, vol. 87, no. 6, pp. 2036–2041, 1991. View at Google Scholar · View at Scopus
  8. G. Daglar, T. Karaca, Y. N. Yuksek et al., “Effect of montelukast and MK-886 on hepatic ischemia-reperfusion injury in rats,” Journal of Surgical Research, vol. 153, no. 1, pp. 31–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Eppihimer, J. Russell, D. C. Anderson, C. J. Epstein, S. Laroux, and D. N. Granger, “Modulation of P-selectin expression in the postischemic intestinal microvasculature,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 273, no. 6, pp. G1326–G1332, 1997. View at Google Scholar · View at Scopus
  10. G. D. Pennock, T. E. Raya, J. J. Bahl, S. Goldman, and E. Morkin, “Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity,” Journal of Pharmacology and Experimental Therapeutics, vol. 263, no. 1, pp. 163–169, 1992. View at Google Scholar · View at Scopus
  11. E. Morkin, G. D. Pennock, P. H. Spooner, J. J. Bahl, and S. Goldman, “Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure,” Thyroid, vol. 12, no. 6, pp. 527–533, 2002. View at Google Scholar · View at Scopus
  12. S. A. Mousa, L. O'Connor, F. B. Davis, and P. J. Davis, “Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated,” Endocrinology, vol. 147, no. 4, pp. 1602–1607, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. Abohashem-Aly, X. Meng, J. Li et al., “DITPA, a thyroid hormone analog, reduces infarct size and attenuates the inflammatory response following myocardial ischemia,” Journal of Surgical Research, vol. 171, no. 2, pp. 379–385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Maitra, C. Adamson, K. Greer et al., “Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril,” Journal of Cardiovascular Pharmacology, vol. 50, no. 5, pp. 526–534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Wiedemann, S. Schneeberger, P. Friedl et al., “The fibrin-derived peptide Bβ15–42 significantly attenuates ischemia-reperfusion injury in a cardiac transplant model,” Transplantation, vol. 89, no. 7, pp. 824–829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Xiu, H. Uchida, H. To et al., “Simplified method of heterotopic rat heart transplantation using the cuff technique: application to sublethal dose protocol of methotrexate on allograft survival,” Microsurgery, vol. 21, no. 1, pp. 16–21, 2001. View at Publisher · View at Google Scholar
  17. M. Zhang, Y. Xu, H. K. Saini, B. Turan, P. P. Liu, and N. S. Dhalla, “Pentoxifylline attenuates cardiac dysfunction and reduces TNF-α level in ischemic-reperfused heart,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 2, pp. H832–H839, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Zingarelli, A. L. Salzman, and C. Szabó, “Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury,” Circulation Research, vol. 83, no. 1, pp. 85–94, 1998. View at Google Scholar · View at Scopus
  19. D. R. Meldrum, “Tumor necrosis factor in the heart,” The American Journal of Physiology, vol. 274, no. 3, pp. R577–R595, 1998. View at Google Scholar · View at Scopus
  20. J. Gurevitch, I. Frolkis, Y. Yuhas et al., “Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion,” Journal of the American College of Cardiology, vol. 28, no. 1, pp. 247–252, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Meldrum, J. C. Cleveland Jr., B. S. Cain, X. Meng, and A. H. Harken, “Increased myocardial tumor necrosis factor-α in a crystalloid-perfused model of cardiac ischemia-reperfusion injury,” Annals of Thoracic Surgery, vol. 65, no. 2, pp. 439–443, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. N. G. Frangogiannis, M. L. Lindsey, L. H. Michael et al., “Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion,” Circulation, vol. 98, no. 7, pp. 699–710, 1998. View at Google Scholar · View at Scopus
  23. C. Kupatt, H. Habazettl, A. Goedecke et al., “Tumor necrosis factor-α contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts,” Circulation Research, vol. 84, no. 4, pp. 392–400, 1999. View at Google Scholar · View at Scopus
  24. M. W. Irwin, S. Mak, D. L. Mann et al., “Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium,” Circulation, vol. 99, no. 11, pp. 1492–1498, 1999. View at Google Scholar · View at Scopus
  25. J. M. Brown, L. S. Terada, M. A. Grosso et al., “Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts,” Journal of Clinical Investigation, vol. 81, no. 4, pp. 1297–1301, 1988. View at Google Scholar · View at Scopus
  26. K. Z. Guyton, Y. Liu, M. Gorospe, Q. Xu, and N. J. Holbrook, “Activation of mitogen-activated protein kinase by H2O2: role in cell survival following oxidant injury,” The Journal of Biological Chemistry, vol. 271, no. 8, pp. 4138–4142, 1996. View at Google Scholar · View at Scopus
  27. A. Herskowitz, S. Choi, A. A. Ansari, and S. Wesselingh, “Cytokine mRNA expression in postischemic/reperfused myocardium,” The American Journal of Pathology, vol. 146, no. 2, pp. 419–428, 1995. View at Google Scholar · View at Scopus
  28. J. Lutz, K. Thürmel, and U. Heemann, “Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation,” Journal of Inflammation, vol. 7, article 27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. L. Kukielka, H. K. Hawkins, L. Michael et al., “Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium,” Journal of Clinical Investigation, vol. 92, no. 3, pp. 1504–1516, 1993. View at Google Scholar · View at Scopus
  30. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, “The inflammatory response in myocardial infarction,” Cardiovascular Research, vol. 53, no. 1, pp. 31–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Bertinchant, A. Polge, E. Robert et al., “Time-course of cardiac troponin I release from isolated perfused rat hearts during hypoxia/reoxygenation and ischemia/reperfusion,” Clinica Chimica Acta, vol. 283, no. 1-2, pp. 43–56, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. P. O. Collinson, F. G. Boa, and D. C. Gaze, “Measurement of cardiac troponins,” Annals of Clinical Biochemistry, vol. 38, no. 5, pp. 423–449, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Bolli and E. Marbán, “Molecular and cellular mechanisms of myocardial stunning,” Physiological Reviews, vol. 79, no. 2, pp. 609–634, 1999. View at Google Scholar
  34. B. Zingarelli, P. W. Hake, A. Denenberg, and H. R. Wong, “Sesquiterpene lactone parthenolide, an inhibitor of IκB kinase complex and nuclear factor-κB, exerts beneficial effects in myocardial reperfusion injury,” Shock, vol. 17, no. 2, pp. 127–134, 2002. View at Google Scholar · View at Scopus
  35. C. Duilio, G. Ambrosio, P. Kuppusamy, A. Dipaula, L. C. Becker, and J. L. Zweier, “Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 280, no. 6, pp. H2649–H2657, 2001. View at Google Scholar · View at Scopus
  36. G. Ambrosio and I. Tritto, “Reperfusion injury: experimental evidence and clinical implications,” The American Heart Journal, vol. 138, no. 2, part 2, pp. S69–S75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. F. G. Al-Amran, N. R. Hadi, and A. M. Hashim, “Leukotriene biosynthesis inhibition ameliorates acute lung injury following hemorrhagic shock in rats,” Journal of Cardiothoracic Surgery, vol. 6, no. 1, article 81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Wang, B. Zhou, J. Li et al., “Inhibitors of 5-lipoxygenase inhibit expression of intercellular adhesion molecule-1 in human melanoma cells,” Acta Pharmacologica Sinica, vol. 25, no. 5, pp. 672–677, 2004. View at Google Scholar · View at Scopus
  39. C. Lawson and S. Wolf, “ICAM-1 signaling in endothelial cells,” Pharmacological Reports, vol. 61, no. 1, pp. 22–32, 2009. View at Google Scholar · View at Scopus
  40. K. B. Reilly, S. Srinivasan, M. E. Hatley et al., “12/15-lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo,” The Journal of Biological Chemistry, vol. 279, no. 10, pp. 9440–9450, 2004. View at Publisher · View at Google Scholar · View at Scopus